ReviewCurrent pain and headache reports2025
Efficacy and Emerging Role of Suprascapular Nerve Block for Pain Management after Shoulder Surgeries.
Review in Current pain and headache reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewPostoperative pain management is an important aspect of shoulder surgery as it directly influences patient recovery, satisfaction, and the overall success of surgical interventions. While the interscalene nerve block (ISB) has been the standard approach for managing pain in these procedures, it is accompanied by a range of adverse effects, including phrenic nerve paralysis and respiratory complications. These drawbacks can complicate recovery and limit rehabilitation efforts. RECENT
findingsIn recent years, the suprascapular nerve block (SSNB) has gained use as a promising alternative for postoperative analgesia in shoulder surgeries, particularly in arthroscopic procedures. This review focuses on a comprehensive analysis of the SSNB, exploring its mechanism of action and comparing its efficacy, safety, and clinical benefits to the ISB. Evidence suggests that SSNB effectively targets the suprascapular nerve, which innervates key structures of the shoulder, providing adequate analgesia with a decreased risk of complications typically associated with ISB. The SSNB is also advantageous in the context of ongoing efforts within healthcare to identify safer, effective opioid-sparing pain management strategies. As the demand for effective pain relief continues to grow, the SSNB stands out as a viable option that could transform the approach to postoperative pain management in shoulder surgery.
Indexed as
Identifiers
41396539What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.